Mecobalamin1 500mcg + Alpha Lipoic Acid100mg + Benfoiamine1Smg + B63mg + Calcium Pantothenate25mg + Folic Acid 1.5mg + Zinc oxide22.5mg + Chromium Picolinate 65mcg + Inositol 10mcg + Lutein 5mg capsule

Mecobalamin1 500mcg + Alpha Lipoic Acid100mg + Benfoiamine1Smg + B63mg + Calcium Pantothenate25mg + Folic Acid 1.5mg + Zinc oxide22.5mg + Chromium Picolinate 65mcg + Inositol 10mcg + Lutein 5mg capsule is a capsule formulated with Mecobalamin1 500mcg + Alpha Lipoic Acid100mg + Benfoiamine1Smg + B63mg + Calcium Pantothenate25mg + Folic Acid 1.5mg + Zinc oxide22.5mg + Chromium Picolinate 65mcg + Inositol 10mcg + Lutein 5mg. The listed active ingredient profile is Mecobalamin1; Alpha Lipoic Acid100mg; Benfoiamine1Smg; B63mg; Calcium Pantothenate25mg; Folic Acid; Zinc oxide22; Chromium Picolinate; Inositol; Lutein, placing the product in the neuropathic pain / neuro-nutritional category. The formulation contains neuropathic-pain and/or neuro-nutritional components used in selected nerve-related conditions under clinician guidance. The source identifies the dosage form as capsule with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.